<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>DAA on Alan Yeung</title>
    <link>https://alan-y.netlify.com/tags/daa/</link>
    <description>Recent content in DAA on Alan Yeung</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <copyright>&amp;copy; 2019 Alan Yeung</copyright>
    <lastBuildDate>Tue, 19 Sep 2023 00:00:00 +0000</lastBuildDate>
    
	<atom:link href="https://alan-y.netlify.com/tags/daa/index.xml" rel="self" type="application/rss+xml" />
    
    
    <item>
      <title>A transient positive association between direct-acting antiviral therapy for hepatitis C infection and drug-related hospitalization among people who inject drugs: Self-controlled case-series analysis of national data</title>
      <link>https://alan-y.netlify.com/publication/journal-article-transient_daa/</link>
      <pubDate>Tue, 19 Sep 2023 00:00:00 +0000</pubDate>
      
      <guid>https://alan-y.netlify.com/publication/journal-article-transient_daa/</guid>
      <description>We investigated associations between outcomes and DAA treatment by comparing post-treatment to baseline periods using a within-subjects design</description>
    </item>
    
    <item>
      <title>Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study</title>
      <link>https://alan-y.netlify.com/publication/journal-article-mortality_treated_hcv/</link>
      <pubDate>Wed, 02 Aug 2023 00:00:00 +0000</pubDate>
      
      <guid>https://alan-y.netlify.com/publication/journal-article-mortality_treated_hcv/</guid>
      <description>This study compared mortality rates for patients treated for hepatitis C in the era of direct acting antivirals with the general population</description>
    </item>
    
    <item>
      <title>Declining incidence of hepatitis C related hepatocellular carcinoma in the era of interferon-free therapies: A population-based cohort study</title>
      <link>https://alan-y.netlify.com/publication/journal-article-hcc-decline/</link>
      <pubDate>Thu, 23 Dec 2021 00:00:00 +0000</pubDate>
      
      <guid>https://alan-y.netlify.com/publication/journal-article-hcc-decline/</guid>
      <description>This study explores the impact of interferon-free therapies on hepatitis C virus related hepatocellular carcinoma at a population level.</description>
    </item>
    
    <item>
      <title>Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs</title>
      <link>https://alan-y.netlify.com/publication/journal-article-hcv_reinf/</link>
      <pubDate>Sat, 09 Oct 2021 00:00:00 +0000</pubDate>
      
      <guid>https://alan-y.netlify.com/publication/journal-article-hcv_reinf/</guid>
      <description>We estimated HCV reinfection rates among PWID in Scotland pre and post-introduction of DAAs.</description>
    </item>
    
    <item>
      <title>Reduction in the population prevalence of HCV viraemia among people who inject drugs associated with scale-up of direct-acting antiviral therapy in community drug services: real world data</title>
      <link>https://alan-y.netlify.com/publication/journal-article-hcv_prev_daa/</link>
      <pubDate>Tue, 02 Mar 2021 00:00:00 +0000</pubDate>
      
      <guid>https://alan-y.netlify.com/publication/journal-article-hcv_prev_daa/</guid>
      <description>We assessed the impact of rapid DAA scale‚Äêup to PWID delivered through community services in the Tayside region of Scotland.</description>
    </item>
    
    <item>
      <title>Population impact of direct-acting antiviral treatment on new presentations of hepatitis C-related decompensated cirrhosis: a national record-linkage study</title>
      <link>https://alan-y.netlify.com/publication/journal-article-hcv_daa_dc/</link>
      <pubDate>Thu, 26 Mar 2020 00:00:00 +0000</pubDate>
      
      <guid>https://alan-y.netlify.com/publication/journal-article-hcv_daa_dc/</guid>
      <description>We examined the impact of the introduction of direct-acting antiviral (DAA) therapies on hepatitis C related decompensated cirrhosis (DC) through analysis of population-based data from Scotland.</description>
    </item>
    
  </channel>
</rss>